Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
Clinical trial NCT05092776 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05092776
- Sponsor
- R-Pharm International, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-29
- Primary completion
- 2025-01-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.